REGISTERED AND RENEWED
on 18 Mar 2024
Last Applicant/ Owned by
Attn: Jonathan Provoost
Monmouth Junction
NJ
08852
Serial Number
85406355 filed on 24th Aug 2011
Registration Number
4425993 registered on 29th Oct 2013
Correspondent Address
Cathy A. Kodroff
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
NEXTWAVE PHARMACEUTICALS
Pharmaceuticals for the treatment [ of hypertension; pharmaceuticals ] for the treatment of attention deficit hyperactivity disorder (ADHD); [ pharmaceuticals for the treatment of cardiovascular diseases; ] pharmaceuticals for the treatment of central nervous system diseases
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals for the treatment [ of hypertension; pharmaceuticals ] for the treatment of attention deficit hyperactivity disorder (ADHD); [ pharmaceuticals for the treatment of cardiovascular diseases; ] pharmaceuticals for the treatment of central nervous system diseases
First Use Date in General
31st Jan 2013
First Use Date in Commerce
31st Jan 2013
Mark Details
Serial Number
No 85406355
Mark Type
No Service/Collective Mark
Attorney Docket Number
No TRIS-NEXTWAV
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 18th Mar 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| 18th Mar 2024 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| 18th Mar 2024 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| 18th Mar 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 13th Oct 2023 | TEAS SECTION 8 & 9 RECEIVED |
| 29th Oct 2022 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 01st Dec 2019 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 01st Dec 2019 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 01st Dec 2019 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 28th Oct 2019 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |